DocDollars

Cipla USA Inc.

NJ · United States · Reporting entity ID 100000141543

Total reported 2019–2025
$22.0M
#300 of 2,960 reporting companies — 0% of all reported industry payments
$2.47M in general payments across 662 records, plus $19.5M in research funding across 6,513 records.

How it breaks down

General payments $2,468,236
Research funding $19,544,921

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Cipla USA Inc. reported $22.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #300 of 2,960 reporting companies. 89% of that was research funding and 11% general payments such as consulting, speaking, food and travel. 662 general payment records and 6,513 research records were filed.

Common questions about Cipla USA Inc.

How much has Cipla USA Inc. paid US doctors?

Cipla USA Inc. reported $22,013,157 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,468,236 in general payments, $19,544,921 in research funding.

How does Cipla USA Inc. rank among drug and device companies?

It ranks #300 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Cipla USA Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.